10-99661618-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020354.5(ENTPD7):c.181C>A(p.Gln61Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000623 in 1,605,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020354.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ENTPD7 | NM_020354.5 | c.181C>A | p.Gln61Lys | missense_variant | 3/13 | ENST00000370489.5 | |
ENTPD7 | NM_001349962.2 | c.187C>A | p.Gln63Lys | missense_variant | 4/14 | ||
ENTPD7 | NM_001349963.2 | c.181C>A | p.Gln61Lys | missense_variant | 3/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ENTPD7 | ENST00000370489.5 | c.181C>A | p.Gln61Lys | missense_variant | 3/13 | 1 | NM_020354.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000495 AC: 12AN: 242264Hom.: 0 AF XY: 0.0000153 AC XY: 2AN XY: 130982
GnomAD4 exome AF: 0.00000619 AC: 9AN: 1453898Hom.: 0 Cov.: 30 AF XY: 0.00000277 AC XY: 2AN XY: 722916
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152062Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74272
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2023 | The c.181C>A (p.Q61K) alteration is located in exon 3 (coding exon 2) of the ENTPD7 gene. This alteration results from a C to A substitution at nucleotide position 181, causing the glutamine (Q) at amino acid position 61 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at